the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Cough, Cold and Sore Throat Remedies - US - May 2009

Published by Mintel International Group Ltd, Contact us : +1-860-674-8796
Published 2009/05 Content info  
Product code MT90160
Price From  US $ 3995 Order/Price list
US $ 3995 Hard Copy
US $ 3995 PDF by E-mail (Site License)
US $ 5495 PDF by E-mail (2 Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

  • Scope and Themes
  • What you need to know
  • Definition
  • Data sources
  • Sales data
  • Consumer survey data
  • Abbreviations and terms
  • Abbreviations
  • Terms
  • Executive Summary
  • Market grows despite recession
  • Drug stores top retailers due to proliferation of pharmacies
  • Diverse drivers fuel the market
  • Johnson & Johnson/McNeil lead but Mucinex grows; private label keeps pace
  • Getting sick
  • Treatment and effectiveness
  • Selecting medicine
  • Race & Hispanic origin
  • Market Size and Forecast
  • Key points
  • Incidence of cold/flu, population factors, low health insurance rates drive sales into the future
  • Ups and downs of FDA regulations and the tightening economy
  • Sales and forecast of cough/cold/sore throat remedies
    • Figure 1: FDMx sales of cough, cold, & throat remedies, at current prices, 2003-13
    • Figure 2: FDMx sales of cough, cold, & throat remedies, at inflation-adjusted prices, 2003-13
  • Walmart sales
  • Competitive Context
  • Homeopathic/natural remedies compete with OTC medicines
  • Many still use home remedies rather than OTC treatments
  • Segment Performance
  • Key points
  • Cold/allergy/sinus tablets comprise more than half of the market
  • Sales of cold/allergy/sinus/sore throat remedies, by segment
    • Figure 3: FDMx sales of cough, cold, & throat remedies, segmented by type, 2006 & 2008
  • Segment Performance--Cold/Allergy/Sinus Tablets
  • Key points
  • Tablets signify convenience, benefit from Rx switch
  • Sales and forecast of cold/allergy/sinus tablets
    • Figure 4: FDMx sales of cold/allergy/sinus tablets, at current prices, 2003-13
  • Segment Performance--Cold/Allergy/Sinus Liquids
  • Key points
  • Liquids hurt by recalls, FDA restrictions
  • Sales and forecast of cold/allergy/sinus liquids
    • Figure 5: FDMx sales s of cold/allergy/sinus liquids, at current prices, 2003-13
  • Segment Performance--Nasal Products
  • Key points
  • Nasal products represent safe alternative to pediatric liquids
  • Sales and forecast of nasal products
    • Figure 6: FDMx sales of nasal products, at current prices, 2003-13
  • Segment Performance--Cough Drops
  • Key points
  • Cough drops also represent convenience and utility
  • Non-medicated positioning and single-symptom relief attractive
  • Sales and forecast of cough drops
    • Figure 7: FDMx sales of cough drops, at current prices, 2003-13
  • Segment Performance--Cough Syrup/Sore Throat Liquids
  • Key points
  • Syrups/sore throat liquids face similar challenges to cold liquids
  • Sales and forecast of cough syrup/sore throat liquids
    • Figure 8: FDMx sales of cough syrup/sore throat liquids, at current prices, 2003-13
  • Retail Channels
  • Key points
  • Drug stores most equated with healthcare
  • Sales of cough, cold, & throat remedies, by channel
    • Figure 9: FDMx sales of cough, cold, & throat remedies, by channel, 2006 and 2008
  • Retail Channels--Drug Stores
  • Key points
  • Pharmacies mean bigger OTC business
  • Store brands give drug channels added advantage
  • Drug store sales of cough, cold and throat remedies
    • Figure 10: U.S. drug store sales of cough, cold, & throat remedies, at current prices, 2003-08
  • Retail Channels--Other: Supermarkets & Mass
  • Key points
  • Other channels without pharmacies have tough time competing
  • Other channel sales of cold/allergy/sinus remedies
    • Figure 11: U.S. other* channel sales of cough, cold, & throat remedies, at current prices, 2003-08
  • Market Drivers
  • Incidence of cold and flu
    • Figure 12: U.S. seasonal flu severity, 2001-08
  • Child, female, and elderly population growth means more sufferers
    • Figure 13: Population, by age, 2004-14
    • Figure 14: Female population, by age, 2004-14
  • Self-diagnosis/treatment trend continues to aid OTC sales
  • Outcome
    • Figure 15: Treating a cough/cold/sore throat/flu, February 2009
  • Growing Hispanic population spells opportunity for OTC remedy marketers
    • Figure 16: Cough/cold/sore throat and related conditions experienced in past 12 months, by race/Hispanic origin, February 2009
  • Bottom line
    • Figure 17: Population, by race and Hispanic origin, 2004-14
  • Leading Companies
  • Key points
  • Johnson & Johnson/McNeil continues to lead
  • Private label benefits from tough economy
  • Manufacturer sales of cough, cold, & throat remedies
    • Figure 18: Manufacturer FDMx sales of cough, cold, & throat remedies in the U.S., 2008 and 2009
  • Brand Share--Cold/Allergy/Sinus Tablets
  • Key points
  • Tylenol and Sudafed drop as Mucinex increases share
  • Private label will stiffen competition in the future
  • Manufacturer and brand sales of cold/allergy/sinus tablets
    • Figure 19: Selected brand FDMx sales and market share of cold/allergy/sinus tablets, 2008-09
  • Brand Share--Cold/Allergy/Sinus Liquids
  • Key points
  • Most leading cold liquids drop, while private label surges
  • Manufacturer and brand sales of cold/allergy/sinus liquids
    • Figure 20: Selected brand FDMx sales and market share of cold/allergy/sinus liquids, 2008-09
  • Brand Share--Nasal Spray/Drops/Inhaler
  • Key point
  • NeilMed outpaces most medicated sprays
  • Manufacturer and brand sales of nasal spray/drops/inhaler
    • Figure 21: Selected brand FDMx sales and market share of nasal spray/drops/inhaler, 2008-09
  • Brand Share--Cough Drops
  • Key points
  • Halls leads with brand extensions, but sales fluctuate
  • Ricola leverages herbal angle
  • Manufacturer and brand sales of cough drops
    • Figure 22: Selected brand FDMx sales and market share of cough drops, 2008-09
  • Brand Share--Cough Syrup/Sore Throat Liquids
  • Key points
  • Wyeth and Adams vie for top position, P&G sees strength in Vicks Custom Care
  • Manufacturer and brand sales of cough syrup/sore throat liquids
    • Figure 23: Selected brand FDMx sales and market share of cough syrup/sore throat liquids, 2008-09
  • Natural Channel/SPINS
  • Natural channel sales of cold and flu remedies
    • Figure 24: Natural product supermarket retail sales of cold and flu remedies, at current and inflation-adjusted prices, 2007-09
  • Implications
  • Natural channel sales by segment
    • Figure 25: Natural product supermarket retail sales of cold and flu remedies by segment, 2007-09
  • Brand Qualities
  • Cough drops vie for originality
  • Store brands leverage value as household budgets tighten
  • Demand for natural/alternative ingredients spurs "natural" positioning bids
  • Symptom-specific comes to the fore with Vicks
  • Innovation and Innovators
  • Natural/homeopathic/herbal remedies
    • Figure 26: Claim trends in decongestive, cough, cold & flu relief launches, 2003-08
  • Non-natural products also making use of natural positioning:
  • Kids' remedies
  • Advertising and Promotion
  • Tylenol
  • Building goodwill
  • Web and TV marketing
    • Figure 27: J&J Tylenol Cold Multi-Symptom Rapid Release, 2008
  • Sudafed
    • Figure 28: J&J Sudafed, 2008
  • Mucinex
    • Figure 29: Adams Respiratory Therapeutics Mucinex DM, 2008
  • Vicks
    • Figure 30: Procter & Gamble Vicks Formula 44 Custom Care, 2008
  • Halls
    • Figure 31: Cadbury Schweppes Halls Naturals, 2008
  • Getting Sick
  • Key points
  • Incidence of cough, cold, sore throat, and related conditions
    • Figure 32: Cough/cold/sore throat and related conditions experienced in past 12 months, by gender and age, February 2009
    • Figure 33: Cough/cold/sore throat and related conditions experienced in past 12 months, by presence of children in household, February 2009
  • Frequency of suffering in past 12 months
    • Figure 34: Number of cold/flu/sinus conditions experienced in past 12 months, by gender and age, July 2007-September 2008
  • Treatment
  • Key points
  • Treatment methods
    • Figure 35: Treating a cough/cold/sore throat/flu, February 2009
  • Women tend towards multi-remedy approach; older adults, vitamins
    • Figure 36: Treating a cough or cold, by gender and age, February 2009
    • Figure 37: Treating a sore throat or flu, by gender and age, February 2009
  • OTC remedy use higher among women, older respondents need convincing
    • Figure 38: Treating cough/cold/sore throat/flu with OTC remedies, by gender and age, February 2009
    • Figure 39: Keeping OTC remedies on hand, by gender and age, February 2009
  • Treatment types
  • Key points
  • Types and kinds of cough syrup and sore throat products used
    • Figure 40: Types of cough syrup and sore throat products used, by gender and age July 2007-September 2008
  • Frequency of use by ailment
    • Figure 41: Frequency of use of cold/allergy/sinus remedies, by gender and age, July 2007-September 2008
    • Figure 42: Number of times during the day cough syrup and sore throat products are used, by gender and age, July 2007-September 2008
  • Cold/allergy/sinus remedy formulas used
    • Figure 43: Cold/allergy/sinus remedy formula used, by gender and age, July 2007-September 2008
  • Effectiveness of Cough/Cold Medicine
  • Key points
  • Attitudes about the efficacy of remedies
    • Figure 44: Effectiveness of cold/cough medicine, February 2009
  • Selecting Medicine
  • Key points
  • Important characteristics when selecting cold/cough medicine
    • Figure 45: Important characteristics when selecting cold/cough medicine, by gender, February 2009
  • Seeking guidance
    • Figure 46: Research and input in selecting cough/cold/sore throat/flu remedies, by gender, February 2009
    • Figure 47: Research and input in selecting cough/cold/sore throat/flu remedies, by age, February 2009
  • Safety Concerns
  • Key point
  • Concerns about medicine safety
    • Figure 48: Concerns about medicine safety, by gender, February 2009
  • Homeopathic and Natural/Alternative Remedies
  • Key points
  • Use of homeopathic remedies
    • Figure 49: Homeopathic remedies for cough/cold/sore throat/flu, by gender, February 2009
    • Figure 50: Homeopathic remedies for cough/cold/sore throat/flu, by age, February 2009
  • Race and Hispanic Origin
  • Key points
  • Treatment among ethnicities
    • Figure 51: Treating a cough/cold/sore throat/flu, by race & Hispanic origin, February 2009
    • Figure 52: Treating cough/cold/sore throat/flu with OTC remedies, by race & Hispanic origin, February 2009
    • Figure 53: Ailments for which cold/allergy/sinus remedies were used in the past 12 months, by race & Hispanic origin, July 2007-September 2008
  • Selecting medicine among ethnicities
    • Figure 54: Research and input in selecting cough/cold/sore throat/flu remedies, by race & Hispanic origin, February 2009
  • Homeopathic remedies and ethnicities
    • Figure 55: Homeopathic remedies for cough/cold/sore throat/flu, by race & Hispanic origin, February 2009
  • Appendix: Other Useful Consumer Tables
  • The impact of children and household size on the market
    • Figure 76: Number of cough/cold/sore throat and related conditions experienced in past 12 months, by presence of children and household size, July 2007-September 2008
    • Figure 77: Keeping OTC remedies on hand, by presence of children and household size, February 2009
    • Figure 78: Ailments for which cold/allergy/sinus remedies were used in the past 12 months, by presence of children and household size, July 2007-September 2008
    • Figure 79: Preferred types of cough syrup and sore throat products, by presence of children and household size, July 2007-September 2008
    • Figure 80: Use of cough syrup, sore throat drops, and cold/allergy/sinus remedies, by presence of children and household size, July 2007-September 2008
    • Figure 81: Important characteristics when selecting cold/cough medicine, by presence of children and household size, February 2009
    • Figure 82: Research and input in selecting cough/cold/sore throat/flu remedies, presence of children and household size, February 2009
  • Another look at remedy usage
    • Figure 83: Use of cough syrup, sore throat drops, and cold/allergy/sinus remedies, by gender and age, July 2007-September 2008
    • Figure 84: Ailments for which cold/allergy/sinus remedies were used in the past 12 months, by gender and age July 2007-September 2008
  • Medicine selection and concerns
    • Figure 85: Important characteristics when selecting cold/cough medicine, by age, February 2009
    • Figure 86: Concerns about medicine safety, by age, February 2009
  • Appendix: Trade Associations
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.